Combined Targeting of mTORC1 and mTORC2 Synergistically Inhibits Proliferation of Hepatocellular Carcinoma Cells: Effects of Everolimus and Ku0063794

被引：0
|
作者：
Kim, Say-June
Choi, Ho-Joong
Kim, Dong-Goo
机构：
[1] Catholic Univ Korea, Dept Surg, Daejeon St Marys Hosp, Taejon, South Korea
[2] Catholic Univ Korea, Buchen St Marys Hosp, Dept Surg, Puchon, South Korea
[3] Catholic Univ Korea, Seoul St Marys Hosp, Dept Surg, Seoul, South Korea
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-268
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [31] Prostaglandin E2 induces activation of mTORC1 and mTORC2 in mast cells: selective utilization of mTORC2 for the regulation of chemotaxis and mediator release
    Jung, Mi-Yeon
    Kuehn, Hye Sun
    Beaven, Michael
    Metcalfe, Dean
    Gilfillan, Alasdair
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [32] Autophagy Is a Survival Mechanism of Acute Myelogenous Leukemia Precursors during Dual mTORC2/mTORC1 Targeting
    Altman, Jessica K.
    Szilard, Amy
    Goussetis, Dennis J.
    Sassano, Antonella
    Colamonici, Marco
    Gounaris, Elias
    Frankfurt, Olga
    Giles, Francis J.
    Eklund, Elizabeth A.
    Beauchamp, Elspeth M.
    Platanias, Leonidas C.
    CLINICAL CANCER RESEARCH, 2014, 20 (09) : 2400 - 2409
  • [33] Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity
    Lee, Seunghyeong
    Byun, Jun-Kyu
    Kim, Na-Young
    Jin, Jonghwa
    Woo, Hyein
    Choi, Yeon-Kyung
    Park, Keun-Gyu
    BMB REPORTS, 2022, 55 (09) : 459 - 464
  • [34] Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
    Espona-Fiedler, M.
    Soto-Cerrato, V.
    Hosseini, A.
    Lizcano, J. M.
    Guallar, V.
    Quesada, R.
    Gao, T.
    Perez-Tomas, R.
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (04) : 489 - 496
  • [35] mTORC2 Restricts mTORC1 Metabolic Function in Dendritic Cells to Limit Their Allostimulatory Activity.
    Dai, H.
    Watson, A.
    Menk, A.
    Stolz, D.
    Delgoffe, G.
    Thomson, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 422 - 422
  • [36] Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo
    Jiang, Shang-jun
    Wang, Shuo
    TUMOR BIOLOGY, 2015, 36 (10) : 8177 - 8184
  • [37] Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes
    Chen, Jun
    Liu, Ke
    Liu, Yang
    Wang, Xue
    Zhang, Zhen
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : 270 - 275
  • [38] OSI-027, a dual mTORC1/mTORC2 inhibitor, induces autophagy in cancer cells
    O'Connor, Matthew
    Mohan, Amrita
    Brady, Suzanne
    Mantis, Christine
    Gokhale, Prafulla C.
    Miglarese, Mark R.
    Barr, Sharon M.
    CANCER RESEARCH, 2011, 71
  • [39] Synergistic Effects of Metformin and Sorafenib on Proliferation and Angiogenesis of HCC Through Suppression of mTORC1, mTORC2 and Ras/Raf/MAPK Pathway
    Ling, Sunbin
    Xie, Haiyang
    Zhou, Lin
    Xu, Xiao
    Zheng, Shusen
    TRANSPLANTATION, 2016, 100 : S177 - S177
  • [40] Targeting mTORC1 suppresses proliferation of keratinocyte stem cells and inhibits skin tumor promotion in mice
    Rho, Okkyung
    Cho, Jiyoon
    DiGiovanni, John
    CANCER RESEARCH, 2014, 74 (19)
12345